2015 Fast Congress Banner  
  • Slide 2
  • Slide 3
  • Slide 1

Join 250+ R&D Teams to Hear Solutions and Case Studies on 3D Cellular Models, Phenotypic Screening, and Cancer Immunotherapy  

Cambridge Healthtech Institute (CHI) is pleased to announce the Third Annual FAST: Functional Analysis and Screening Technologies Congress. Now in its third year, the FAST Congress brings you the latest technologies and research in cellular screening.

The Third Annual Phenotypic Drug Discovery meeting will return with new updates and case studies in phenotypic screening, high-content analysis, physiologically-relevant cellular models, chemical genomics and chemical proteomics. The rapidly evolving area of 3D cellular models will be addressed by two back-to-back meetings, with the Inaugural 3D Cell Culture: Organoid, Spheroid, and Organ-on-a-Chip Models meeting focusing on the new predictive cellular models for drug discovery and toxicity assessment. It will review the use of primary and stem cells, complex co-culture cell models, tumor spheroid models, novel organ-on-a-chip models for efficacy and safety screening, functional analysis, and compound profiling. The Third Annual Screening and Functional Analysis of 3D Models meeting will follow with case studies of phenotypic and high-content screening of complex 3D cellular systems for compound and target selection. And finally, a new addition this year is the Inaugural Screening Strategies for Cancer Immunotherapy meeting, which will focus on in vitro models of the tumor microenvironment for immunotherapy target and biologics discovery, predictive preclinical models, more informative antibody screening strategies, and cancer cell therapy development.

The 2014 Congress attracted more than 250 senior delegates, representing over 160 companies from 20 countries. With half of the attendees from big pharma and biotech and a third from academia and government, the FAST Congress offers exclusive networking opportunities with diverse international attendance. Please join our focused Screening event and learn from 60+ scientific presentations, an assortment of educational courses, 20+ exhibitors and your fellow expert delegates. We look forward to seeing you at the event.

2015 FEATURED SPEAKERS

Hicham Alaoui, Ph.D., Director, Biochemical and Cellular Pharmacology, Genentech

Treena Arinzeh, Ph.D., Professor, Biomedical Engineering, New Jersey Institute of Technology

Anne Bang, Ph.D., Director, Cell-Based Disease Modeling and Screening, Sanford-Burnham Medical Research Institute

Andras Bauer, Ph.D., Senior Scientist, Immunology and Inflammation, Boehringer-Ingelheim

Anne E. Carpenter, Ph.D., Director, Imaging Platform, Broad Institute of Harvard and MIT

Arijit Chakravarty, Ph.D., Director, Modeling and Simulation, Takeda Pharmaceuticals

Anthony M. Davies, Ph.D., Center Director, Translational Cell Imaging Queensland (TCIQ), Institute of Health Biomedical Innovation, Queensland University of Technology

Eugen Dhimolea, Ph.D., Instructor, Medicine, Dana-Farber Cancer Institute, Harvard Medical School

Sharon Gerecht, Ph.D., Associate Professor, Chemical & Biomolecular Engineering, Johns Hopkins University

Su Guo, Ph.D., Professor, Bioengineering and Therapeutic Sciences, University of California, San Francisco

Shane Horman, Ph.D., Research Investigator, Genomics Institute of the Novartis Research Foundation 

Dan Dongeun Huh, Ph.D., Chair & Assistant Professor, Bioengineering, University of Pennsylvania

Esmaiel Jabbari, Ph.D., Professor of Chemical and Biomedical Engineering, Chemical Engineering, University of South Carolina

Lorin Jakubek, Ph.D., Post Doc Associate, Predictive Toxicology, Sanofi

Doo Yeon Kim, Ph.D., Assistant Professor, Neurology, Genetics and Aging Research Unit, Massachusetts General Hospital, Harvard Medical School

Sophie A. Lelièvre, D.V.M., LLMPH, Ph.D., Associate Professor, Cancer Pharmacology, Purdue University

Jing Li, Ph.D., Director, Genomics and Phenotypic Screening, Merck Research Laboratories

Jesse Lugus, Ph.D., Research Investigator, Developmental & Molecular Pathways, Novartis Institutes for BioMedical Research

Alison  McGuigan, Ph.D., Assistant Professor, Chemical Engineering and Applied Chemistry, University of Toronto

Lisa Minor, Ph.D., President, In Vitro Strategies, LLC 

David Nolte, Ph.D., Professor, Physics, Purdue University; President, Animated Dynamics, Inc.

Donna Peehl, Ph.D., Research Professor, Urology, Stanford University

Kaushal Rege, Ph.D., Associate Professor, Chemical Engineering, Arizona State University, Tempe, AZ

Imran Rizvi, Ph.D., Instructor, Medicine and Dermatology, Brigham and Women's Hospital, Harvard Medical School

Christian Schmees, Ph.D., Head, Tumor Biology, NMI Natural and Medical Sciences Institute at the University of Tübingen

Serena Silver, Ph.D., Senior Investigator & Group Leader, Molecular Pharmacology, Novartis

Lena Smirnova, Ph.D., Research Associate, Johns Hopkins Center for Alternatives to Animal Testing, Johns Hopkins University Bloomberg School of Public Health 

Per Erik Stromstedt, Ph.D., Director, Screening Sciences & Sample Management/Reagent & Assay Development, AstraZeneca R&D

Wei Sun, Ph.D., Scientist, Therapeutics for Rare and Neglected Diseases (TRND), National Center for Advancing Translational Sciences (NCATS)

David C. Swinney, Ph.D., CEO, Institute for Rare and Neglected Diseases Drug Discovery (iRND3)

O. Berk Usta, Ph.D., Instructor, Surgery, Center for Engineering in Medicine, Massachusetts General Hospital, Harvard Medical School

Fabien Vincent, Ph.D., Associate Research Fellow, Hit Discovery and Lead Profiling, Pfizer

Muhammad H. Zaman, Ph.D., Professor, Howard Hughes Medical Institute; Professor, Biomedical Engineering and International Health, Boston University

For questions or suggestions about the meeting, please contact:
Julia Boguslavsky
Executive Director, Conferences
Cambridge Healthtech Institute (CHI)
E-mail: juliab@healthtech.com

For sponsorship and exhibit sales information, please contact:
Katelin Fitzgerald
Senior Business Development Manager
Cambridge Healthtech Institute (CHI)
Phone: (+1) 781-972-5458
Email: kfitzgerald@healthtech.com
 

For media and association partnerships, please contact:
James Prudhomme
Senior Marketing Manager
Cambridge Healthtech Institute (CHI)
Phone (+1) 781-972-5486
Email: jprudhomme@healthtech.com
 

For media and association partnerships, please contact:
Jaime Hodges
Marketing Manager
Cambridge Healthtech Institute (CHI)
Phone (+1) 781-972-5429
Email: jhodges@healhtech.com
 

Quotes